Last reviewed · How we verify
NCT06876818: PREDICT-OMICS
Predictive Cardio-Metabolic Trascrictomics Trajectories In The Barilla Offspring Follow-Up Study
trial testing Evaluation of transcriptomic and cardio-metabolic profiles in Healthy Volunteer in 110 participants. Participants enrolled and being followed up; not accepting new ones.
1 July 2025
Quick facts
| Lead sponsor | Azienda Ospedaliero-Universitaria di Parma |
|---|---|
| Status | Active, enrolled |
| Study type | OBSERVATIONAL |
| Enrollment | 110 |
| Start date | 23 May 2024 |
| Primary completion | 1 July 2025 |
| Estimated completion | 31 December 2025 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Evaluation of transcriptomic and cardio-metabolic profiles
Conditions studied
- Healthy Volunteer — all drugs for Healthy Volunteer →
Sponsor
Azienda Ospedaliero-Universitaria di Parma — full company profile →
Who can join
18 and older, any sex, with Healthy Volunteer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Experimental, drug-free, longitudinal, single-centre study for the prediction of cardiometabolic risk in Barilla Off-Spring Study subjects by analysing the evolution of transcriptomic signatures
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06876818
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Healthy Volunteer
Currently open trials in the same condition.
- NCT06274749 — Effects of Urolithin A Supplementation on Glucose Metabolism in Healthy Adults 55 >= Years Old: A Randomized Triple-Mask · NA · recruiting
- NCT05652478 — Early Metabolic Effects of Antiretroviral Drugs in Healthy volUnteers: a Phase 2 Randomized Study · Phase 2 · recruiting
- NCT06845176 — Combining Motor Imagery and Tendon Vibration on the Effectiveness of Motor Imagery · NA · recruiting
- NCT07439263 — Single Ascending Dose Study of HB2198 in Healthy Participants · Phase 1 · recruiting
- NCT07220122 — Impact of Exogenous Ketones on Breathing in Healthy Volunteers · EARLY_PHASE1 · recruiting
Other Azienda Ospedaliero-Universitaria di Parma trials
Trials by the same sponsor.
- NCT07360366 — Interprofessional Collaboration in the Cardiac Intensive Care Unit (CICU): An Action-Research Training Project · NA · not yet recruiting
- NCT06888167 — Food (Poly)Phenol Metabotypes and Beta-cell Mass and Function. · NA · recruiting
- NCT07419178 — A New Diagnostic Algorithm to Non-invasively Track Fibrotic Changes in Myeloproliferative Neoplasms Based on C-C Chemoki · NA · recruiting
- NCT05936944 — Role of Natural Light in the Prevention of Delirium After Cardiac Surgery: a Prospective Observational Study With Histor · completed
- NCT06626893 — Integrative "Omics" Approaches for Leukemia Target Identification and Matched Therapeutic Intervention · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06876818 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Azienda Ospedaliero-Universitaria di Parma
- Last refreshed: 14 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06876818.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing